Ajani JA - Search Results

1

Navigating Nodal Metrics for Node-Positive Gastric Cancer in the United States: An NCDB-Based Study and Validation of AJCC Guidelines.

Erstad DJ, Blum M, Estrella JS, Das P, Minsky BD, Ajani JA, Mansfield PF, Ikoma N, Badgwell BD. Erstad DJ, et al. Among authors: ajani ja. J Natl Compr Canc Netw. 2021 Oct 22:1-12. doi: 10.6004/jnccn.2021.7038. Online ahead of print. J Natl Compr Canc Netw. 2021. PMID: 34678759

2

CPT-11 plus cisplatin in patients with advanced, untreated gastric or gastroesophageal junction carcinoma: results of a phase II study.

Ajani JA, Baker J, Pisters PW, Ho L, Mansfield PF, Feig BW, Charnsangavej C. Ajani JA, et al. Cancer. 2002 Feb 1;94(3):641-6. doi: 10.1002/cncr.10279. Cancer. 2002. PMID: 11857295 Free article. Clinical Trial.

3

Peritoneal and serum tumor markers predict recurrence and survival of patients with resectable gastric cancer.

Bold RJ, Ota DM, Ajani JA, Mansfield PF. Bold RJ, et al. Among authors: ajani ja. Gastric Cancer. 1999 May;2(1):1-7. doi: 10.1007/s101200050013. Gastric Cancer. 1999. PMID: 11957063

4

Irinotecan/cisplatin in advanced, treated gastric or gastroesophageal junction carcinoma.

Ajani JA, Baker J, Pisters PW, Ho L, Mansfield PF, Feig BW, Charnsangavej C. Ajani JA, et al. Oncology (Williston Park). 2002 May;16(5 Suppl 5):16-8. Oncology (Williston Park). 2002. PMID: 12109800 Free article. Clinical Trial.

5

Adenocarcinoma of the stomach in patients age 35 years and younger: no impact of early diagnosis on survival outcome.

Windham TC, Termuhlen PM, Ajani JA, Mansfield PF. Windham TC, et al. Among authors: ajani ja. J Surg Oncol. 2002 Nov;81(3):118-24; discussion 124-5. doi: 10.1002/jso.10157. J Surg Oncol. 2002. PMID: 12407722

6

Combined-modality therapy for gastric cancer.

Yao JC, Mansfield PF, Pisters PW, Feig BW, Janjan NA, Crane C, Ajani JA. Yao JC, et al. Among authors: ajani ja. Semin Surg Oncol. 2003;21(4):223-7. doi: 10.1002/ssu.10040. Semin Surg Oncol. 2003. PMID: 14648779 Review.

7

Prognostic significance of CpG island methylator phenotype and microsatellite instability in gastric carcinoma.

An C, Choi IS, Yao JC, Worah S, Xie K, Mansfield PF, Ajani JA, Rashid A, Hamilton SR, Wu TT. An C, et al. Among authors: ajani ja. Clin Cancer Res. 2005 Jan 15;11(2 Pt 1):656-63. Clin Cancer Res. 2005. PMID: 15701853

8

Clinicopathologic behavior of gastric adenocarcinoma in Hispanic patients: analysis of a single institution's experience over 15 years.

Yao JC, Tseng JF, Worah S, Hess KR, Mansfield PF, Crane CH, Schnirer II, Reddy S, Chiang SS, Najam A, Yu C, Giacco GG, Xie K, Wu TT, Feig BW, Pisters PW, Ajani JA. Yao JC, et al. Among authors: ajani ja. J Clin Oncol. 2005 May 1;23(13):3094-103. doi: 10.1200/JCO.2005.08.987. J Clin Oncol. 2005. PMID: 15860869

9

Gastric and gastro-oesophageal cancer therapy.

Das P, Ajani JA. Das P, et al. Among authors: ajani ja. Expert Opin Pharmacother. 2005 Dec;6(16):2805-12. doi: 10.1517/14656566.6.16.2805. Expert Opin Pharmacother. 2005. PMID: 16318431 Review.

10

Combined modality therapy of localized gastric and esophageal cancers.

Das P, Fukami N, Ajani JA. Das P, et al. Among authors: ajani ja. J Natl Compr Canc Netw. 2006 Apr;4(4):375-82. doi: 10.6004/jnccn.2006.0032. J Natl Compr Canc Netw. 2006. PMID: 16569390 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

776 results

Search Page